Cytek Biosciences, Inc.Cytek Biosciences, Inc.Cytek Biosciences, Inc.

Cytek Biosciences, Inc.

No trades
See on Supercharts

Price target

5.600.000.00%
The 5 analysts offering 1 year price forecasts for CTKB have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to CTKB in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


CTKB EPS for the last quarter is −0.09 USD despite the estimation of −0.03 USD. In the next quarter EPS is expected to reach −0.03 USD. Track more of Cytek Biosciences, Inc. financials and stay on top of what is up with the company.
In the next quarter Cytek Biosciences, Inc. revenue is expected to reach ‪46.03 M‬ USD. Check out Cytek Biosciences, Inc. revenue and earnings and make informed decisions.
According to analysts, CTKB price target is 5.60 USD with a max estimate of 9.00 USD and a min estimate of 3.00 USD. Check if this forecast comes true in a year, meanwhile watch Cytek Biosciences, Inc. stock price chart and keep track of the current situation with CTKB news and stock market news.
We've gathered opinions of 6 analysts rating CTKB stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.